citrulline has been researched along with Acquired Metabolic Diseases, Brain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlemeyer, B; Assmann, B; Exner-Camps, S; Hoffmann, GF; Hörster, F; Kohlmüller, D; Kölker, S; Krieglstein, J; Mayatepek, E; Okun, JG | 1 |
Ichikawa, M; Iuchi, H; Kimura, Y; Kitai, K; Kondo, T; Yamashita, Y | 1 |
2 other study(ies) available for citrulline and Acquired Metabolic Diseases, Brain
Article | Year |
---|---|
3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis.
Topics: Animals; beta-Alanine; Brain Diseases, Metabolic; Calcium; Cell Death; Cells, Cultured; Central Nervous System; Chick Embryo; Citrulline; Electron Transport; Energy Metabolism; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Formamides; Glutamic Acid; Mitochondria; Neurons; Neurotoxins; Oxidative Stress; Propionates; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Urea | 2001 |
[Usefulness of continuous peritoneal dialysis (CPD) in the management of metabolic encephalopathy in adult type citrullinemia].
Topics: Administration, Oral; Brain Diseases, Metabolic; Carbon; Citrulline; Humans; Male; Middle Aged; Oxides; Peritoneal Dialysis, Continuous Ambulatory | 1989 |